This finding is consistent with previous study showing that EpiSen-high cells (identified as AXL-CLDN4+ cells; EpiSen: epithelial senescence) were more sensitive to EGFR and PI3K inhibitors in 2 head and neck squamous cell carcinoma cell lines [29]. The gene discussed is CLDN4; the disease is head and neck squamous cell carcinoma.